Trial Profile
Intermezzo (Zolpidem Tartrate) Sublingual Tablet C-IV: Pk/Pd Profile Supports Middle-of-the-Night Dosing of 1.75 Mg in Women and 3.5 Mg in Men
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 20 Jan 2014
Price :
$35
*
At a glance
- Drugs Zolpidem (Primary)
- Indications Insomnia
- Focus Therapeutic Use
- 06 Nov 2013 Results published in the Journal of Clinical Pharmacology.
- 11 Jul 2012 New trial record